Brazikumab (Anti-IL-23)
Brazikumab (Anti-IL-23) (A2965-GRP)
Products
Description
Brazikumab (Anti-IL-23) is a human IgG2 monoclonal antibody that selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for research on Crohn's disease. MW: 144.82 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2965 |
| Target | Interleukins |